Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

Cell

Volumn 90, Issue 4, 1997, Pages 595-606

  Gu, Wei ^a   Roeder, Robert G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; HISTONE; PROTEIN P53; TRANSCRIPTION FACTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONFORMATIONAL TRANSITION; DNA BINDING; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0030797585     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80521-8     Document Type: Article

References (83)

1. Alland, L., Muhle, R., Hou, H., Potes, J., Chin, L., Schreiber-Agus, N., and DePino, R.A. (1997). Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 357, 49-55.
2. Archer, T.K., Lefebvre, P., Wolford, R.G., and Hager, G.L. (1992). Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 255, 1573-1576.
3. Arany, Z., Newsome, D., Oldread, E., Livingston, D.M., and Eckner, R. (1995). A family of transcriptional adaptor proteins targeted by the E1a oncoprotein. Nature, 374, 81-84.
4. Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montiminy, M. (1994). Activation of cAMP and mitogen responsive gene relies on a common nuclear factor. Nature 370, 226-229.
5. Bannister, A.J., and Kouzarides, T. (1995). CBP-induced stimulation of c-Fos activity is abrogated by E1a. EMBO J. 14, 4758-4762.
6. Bannister, A.J., and Kouzarides, T. (1996). The CBP coactivator is a histone acetyltransferase. Nature 384, 641-643.
7. Barak, Y.T., Juven, T., Haffner, R., and Oren, M. (1993). mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468.
8. Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andre, A., and Livingston, D.M. (1996). Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383, 344-347.
9. Blackwood, E.M., and Eisenman, R.N. (1991). Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc. Science 251, 1211-1217.
10. Brownell, J.E., and Allis, C.D. (1996). Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 6, 176-184.
11. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B.R., and Kley, N. (1995). Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646-649.
12. Buckley, A., Left, M.A., Buckley, D.J., Magnuson, N.S., de Jong, G., and Gout, P.W. (1996). Alteration in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells. Cell Growth Differ. 7, 1713-1721.
13. Candau, R., Zhou, J.X., Allis, C.D., and Berger, S.L. (1997). Histone acetyltransferase activity and interaction with ADA2 are critical for GCN5 function in vivo. EMBO J. 16, 555-565.
14. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima, T., Schulman, I.G., Juguilon, H., Motminy, M., and Evans, R.M. (1996). Roles of CBP/p300 in nuclear receptor signaling. Nature 383, 99-103.
15. Chen, W.Y., Bailey, E.C., McCune, S.L., Dong, J-Y., and Townes, T.M. (1997). Reaction of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl. Acad. Sci. USA 94, 5798-5803.
16. Chiang, C.M., and Roeder, R.G. (1993). Expression and purification of general transcriptional factors by Flag epitope-tagging and peptide elution. Peptide Res. 6, 62-64.
17. Chresta, C.M., and Hickman, J.A. (1996). Oddball p53 in testicular tumors. Nat. Med. 2, 745-746.
18. Chrivia, J.C., Kwok, R.P., Lamb, N., Hagiwara, M., Montiminy, M.R., and Goodman, R.H. (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859.
19. Crook, T., Marston, N.J., Sara, E.A., and Vousden, K.H. (1994). Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79, 817-827.
20. Dai, P., Akimaru, H., Tanaka, Y., Hou, D.X., Yasukawa, T., Kanei-Ishii, C., Takahashi, T., and Ishii, S. (1996). CBP as a transcriptional coactivaor of c-Myb. Genes Dev. 10, 528-540.
21. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W., and Vogelstein, B. (1992). Definition of a consensus binding site for p53. Nat. Genet. 7, 45-49.
22. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parson, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
23. Engel, K., Schultz, H., Martin, F., Kotyarov, A., Plath, K., Hahn, M., Heinemann, U., and Gaestel, M. (1995). Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phophorylation sites and α-helix motif. J. Biol. Chem. 270, 27213-27221.
24. Fiscella, M., Zambrano, N., Ullrich, S.J., Unger, T., Lin, D., Cho, B., Mercer, W.E., Andersen, C.W., and Appella, E. (1994). The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene 9, 3249-3257.
25. Funk, W.D., Pak, D.T., Karas, R.H., Wright, W.E., and Shay, J.W. (1992). A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12, 2866-2871.
26. Gerristen, M., William, A., Neish, A., Moore, S., Shi, Y., and Collins, T. (1997). CREB-binding protein CBP/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94, 2927-2932.
27. Gottlieb, T.M., and Oren, M. (1996). p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287, 77-102.
28. Gregor, P.D., Sawadogo, M., and Roeder, R.G. (1990). The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4, 1730-1740.
29. Gu, W., Shi, X.L., and Roeder, R.G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-823.
30. Gu, W., Bhatia, K., Magrath, I.T., and Dalla-Favera, R. (1994). Binding and suppression of the Myc transcriptional activation domain by p107. Science 264, 251-254.
31. Hall, S.R., Campbell, L.E., and Meek, D.W. (1996). Phosphorylation of p53 at the casein kinase site selectively regulates p53-dependent transcriptional repression but not transactivation. Nucleic Acids Res. 24, 1119-1126.
32. Hansen, R., and Oren, M. (1997). p53; from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7, 46-51.
33. Hassig, C.A., Fleischer, T.C., Billin, A.N., Schreiber, S.L., and Ayer, D.E. (1997). Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341-347.
34. Heinzel, T., Lavinsky, R.M., Mullen, T., Soderstom, M., Laherty, C., Torchia, J., Yang, W., Brard, G., Ngo, S., Davie, J., et al. (1997). A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43-48.
35. Hendzel, M.J., Delcuve, G.P., and Davie, J.R. (1991). Histone deacetylase is a component of the internal nuclear matrix. J. Biol. Chem. 15, 21936-21942.
36. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. (1991). p53 mutations in human cancers. Science 253, 49-53.
37. Hupp, T.R., Sparks, A., and Lane, D.P. (1995). Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237-245.
38. Hupp, T.R., and Lane, D.P. (1994). Allosteric activation of latent p53 tetramers. Curr. Biol. 4, 865-875.
39. Hupp, T.R., Meek, D.W., Midgley, C.A., and Lane, D.P. (1992). Regulation of specific DNA binding function of p53. Cell 71, 875-886.
40. Jayaraman, L., and Prives, C. (1995). Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C terminus. Cell 81, 1021-1029.
41. Kadosh, D., and Struhl, K. (1997). Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters. Cell 89, 365-371.
42. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Purokawa, R., Gloss, B., Lin, S., Heyman, B., Rose, D., Glass, C.K., and Rosenfeld, M.G. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
43. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311.
44. Kastan, M.B., Zhan, Q., El-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B., and Fornace, A.J., Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasis. Cell 71, 587-597.
45. Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S., and Beppu, T. (1993). Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 268, 22429-22435.
46. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
47. Kuo, M.H., Brownell, J.E., Sobel, R.E., Ranalli, T.A., Cook, R.G., Edmondson, D.G., Roth, S.Y., and Allis, C.D. (1996). Transcription-linked acetylation by GCN5p of histone H3 and H4 at specific lysines. Nature 383, 269-272.
48. Kwok, R., Lundblad, J., Chriva, J., Richards, J., Bachinger, H., Brennan, R., Roberts, S., Green, M., and Goodman, R. (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226.
49. Laherty, C.D., Yang, W.M., Sun, J.M., Davie, J.R., Seto, E., and Eisenman, R.N. (1997). Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89, 349-356.
50. Lee, S., Elenbaas, B., Levine, A., and Griffith, J. (1995). p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81, 1013-1020.
51. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
52. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J., and Livingston, D.M. (1997). Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823-827.
53. Lu, H., and Levine, A.J. (1995). Human TAF31 protein is transcriptional activation coactivator of p53 protein. Proc. Natl. Acad. Sci. USA 92, 5154-5158.
54. Lundblad, J.R., Kwok, R.P., Laurance, M.E., Harter, M.L., and Goodman, R.H. (1995). Adenoviral E1a-associated protein p300 as a functional homologue of the transcriptional coactivator CBP. Nature 374, 85-88.
55. Lutzker, S.G., and Levine, A.J. (1996). A functionally inactive p53 protein in teracarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med. 2, 804-810.
56. Marston, N.J., Crook, T., and Vousden, K.H. (1994). Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function. Oncogene 9, 2707-2716.
57. Meek, D. (1994). Post-translational modification of p53. Semin. Cancer Biol. 5, 203-210.
58. Miyashita, T., and Reed, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
59. ∥250 subunit of TFIID has histone acetyltransferase activity. Cell 87, 1261-1270.
60. Mohammadi, M., Schlessinger, J., and Hubbard, S.R. (1996). Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86, 577-587.
61. Nagy, L., Kao, H.Y., Chakravarti, D., Lin, R.J., Hassig, C.A., Ayer, D.E., Schreiber, S.L., and Evans, R.M. (1997). Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380.
62. Nakajima, T., Uchida, C., Anderson, S., Pavin, J., and Montiminy, M. (1997). Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11, 738-747.
63. Oelgeschlager, M., Janknecht, R., Krieg, J., Schreek, S., and Luscher, B. (1996). Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J. 15, 2771-2780.
64. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996). The transcriptional coactivator p300 and CBP are histone acetyltransferases Cell 87, 953-959.
65. Okamoto, K., and Beach, D. (1994). Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13, 4816-4822.
66. Pazin, M.J., and Kadonaga, J.T. (1997). What's up and down with histone deacetylation and transcription. Cell 89, 325-328.
67. Pietenpol, J.A., Tokino, T., Thiagalingam, S., El-Deiry, W.S., Kinzler, K.W., and Vogelstein, B. (1994). Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91, 1998-2002.
68. Ptashne, M., and Gann, A. (1997). Transcriptional activation by recruitment. Nature 386, 569-577.
69. Selivanova, G., Iotsova, V., Okan, I., Fritsche, M., Storm, M., Groner, B., Crafstrom, R.C., and Wiman, K.G. (1997). Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat. Med. 3, 632-638.
70. Shaw, P., Freeman, J., Bovey, R., and Iggo, R. (1996). Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12, 921-930.
71. Soussi, T., de Fromentel, C.C., and May, P. (1990). Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5, 945-952.
72. Shikama, N., Lyon, J., and La Thangue, N.B. (1997). The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7, 230-236.
73. ∥60. Science 267, 100-104.
74. Turner, B.M. (1993). Decoding the nucleosome. Cell 75, 5-8.
75. Van Lint, C., Emiliani, S., Ott, M., and Verdin, E. (1996). Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15, 1112-1120.
76. Vettese-Dadey, M., Grant, P.A., Hebbes, T.R., Crane-Robinson, C., Allis, C.D., and Workman, J.L. (1996). Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 15, 2508-2518.
77. Wolffe, A.P., and Pruss, D. (1996). Targeting chromatin disruption: transcription regulators that acetylate histones. Cell 86, 817-819.
78. Wu, X., Bayle J.H., Olsen D., and Levine A.J. (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132.
79. Yang, X.J., Ogryzko, V., Nishikawa, J., Howard, B., and Nakatani, Y. (1996). A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1a. Nature 382, 319-324.
80. Yoshida, M., Horinouchi, S., and Beppu, T. (1995). Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. BioEssays 5, 423-430.
81. Yuan, W., Condorelli, G., Caruso, M., Felsani, A., and Giordano, A. (1996). Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271, 9009-9013.
82. Zhang, J.J., Vinkemeier, U., Gu, W., Chakravarti, D., Horvath, C.M., Darnell, J.E., Jr. (1996). Two contact regions between Stat1 and CBP/p300 in Interferon gamma signaling. Proc. Natl. Acad. Sci. USA 93, 15092-15096.
83. Zhang, Y., Iratni, R., Erdjument-Bromage, H., Tempst, P., and Reinberg, D. (1997). Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89, 357-364.